Your session is about to expire
What is Baqsimi
Approved as Treatment by the FDA
Glucagon, otherwise called Glucagon, is approved by the FDA for 3 uses including Hypoglycemia and severe Hypoglycemia .Effectiveness
When to interrupt dosage
The recommended dosage of Baqsimi depends on the determined condition, such as Gastrointestinal tract structure, Type 2 Diabetes and Type 2 Diabetes. The dose varies in accordance with the mode of delivery (e.g. Intramuscular; Intravenous; Subcutaneous or Injection, powder, for solution - Intramuscular; Intravenous; Subcutaneous) specified in the table below.Warnings
Baqsimi ContraindicationsBaqsimi Novel Uses: Which Conditions Have a Clinical Trial Featuring Baqsimi?
248 active clinical trials are being conducted to examine the potential of Baqsimi for alleviating Type 2 Diabetes, Hypoglycemia and Type 2 Diabetes Mellitus.Baqsimi Reviews: What are patients saying about Baqsimi?
Patient Q&A Section about baqsimi
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.When should I take BAQSIMI?
"If your blood sugar falls from a low level to a very low level, you may have very low blood sugar and need BAQSIMI. BAQSIMI should be used in an emergency situation where you cannot eat or drink and need assistance from someone else."
What is BAQSIMI used for?
"BAQSIMI is a dry nasal spray used to treat very low blood sugar in people with diabetes. It is the first and only treatment of its kind."
How much does BAQSIMI raise blood sugar?
"In clinical studies, Baqsimi has been shown to raise blood sugar back to normal levels in 98.8% to 100% of adults within 11.6 to 15.9 minutes."
Is glucagon the same as BAQSIMI?
"The active ingredient in BAQSIMI, glucagon, has been in use for many years. In a clinical study, BAQSIMI was shown to be just as effective as glucagon injections in raising blood sugar levels in adults. BAQSIMI is available in a single dose form, which is the same for people aged 4 and up."